3651 results for «301»

Filter By

3651 results

The Future of TAVI

19 May 2022 – From EuroPCR 2022

Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.

The Future of TAVI

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

Advances in left main bifurcation PCI and renal denervation

06 Oct 2022 – From AICT-ASIAPCR 2022

Discover more about treatment strategies and recent evidence for left main bifurcation, the latest Malaysian Working Group consensus statement on renal denervation, as well as reviewing patient-centred clinical judgement and individualised treatment plans.

Advances in left main bifurcation PCI and renal denervation

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

06 Oct 2022 – From AICT-ASIAPCR 2022

In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

Beginning with the end in mind - FFR vs. IVUS imaging

06 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session if you want to explore different plaque modification techniques and technology and see how to maximise PCI outcome with IVUS imaging. Also assess when to select FFR to determine when to treat vs. IVUS to determine where and how to treat.

Beginning with the end in mind

Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm

07 Oct 2022 – From AICT-ASIAPCR 2022

With this session, keep up to date on the evidence, trials and outcome data for intravascular lithotripsy in severely calcified lesions. Learn how to use this technique in real-world patients and understand its role in the treatment algorithm for severely calcified coronary lesions.

Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Precision PCI - Simplifying the complex - Learn from the masters

07 Oct 2022 – From AICT-ASIAPCR 2022

This session will help you better understand the influence of stent design, drug and polymer on the procedural short and long-term outcomes, the use of OCT in PCI of complex coronary lesions and the role, prevalence and diagnosis of microvascular dysfunction in patients with ischaemia and...

Precision PCI - Simplifying the complex - Learn from the masters

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
Didn’t find what you were looking for?